Chargement en cours...

Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis

Studies comparing the effects of natalizumab and fingolimod in relapsing–remitting multiple sclerosis (RRMS) are limited. We aimed to compare natalizumab and fingolimod effects on clinical, neuropsychological, and MRI measures in RRMS patients after 2 years of treatment. RRMS patients starting natal...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neurotherapeutics
Auteurs principaux: Preziosa, Paolo, Rocca, Maria A., Riccitelli, Gianna C., Moiola, Lucia, Storelli, Loredana, Rodegher, Mariaemma, Comi, Giancarlo, Signori, Alessio, Falini, Andrea, Filippi, Massimo
Format: Artigo
Langue:Inglês
Publié: Springer International Publishing 2019
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7007466/
https://ncbi.nlm.nih.gov/pubmed/31452082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-019-00781-w
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!